## AFL: Aflac Incorporated - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 0.8% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($108.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Aflac Selects CyEx's Medical Shield to Provide Medical Fraud Protection for Individuals Impacted by Data Breach**
- Source: PR Newswire | 20260106T140814 | Somewhat-Bullish | Relevance: 100%
- Aflac has chosen CyEx's Medical Shield to provide medical fraud protection for 22.65 million individuals affected by a recent cyberattack. Recognizing the sensitive personal health information potentially exposed, Aflac opted for Medical Shield's comprehensive monitoring and insurance coverage, going beyond standard credit monitoring. This decision highlights Aflac's commitment to robust protection against the growing threat of medical identity theft.

**2. Robeco Institutional Asset Management B.V. Has $176.29 Million Stock Position in Aflac Incorporated $AFL**
- Source: MarketBeat | 20260106T120352 | Somewhat-Bullish | Relevance: 100%
- Robeco Institutional Asset Management B.V. reduced its stake in Aflac Incorporated (NYSE:AFL) by 4.6% in the third quarter, now holding 1,578,210 shares worth $176.29 million. Other institutional investors have also adjusted their positions, and 67.44% of Aflac's stock is institutionally owned. Analysts have issued varied ratings, with a consensus "Hold" and a target price of $110.92, while company insiders have recently sold shares.

**3. Aflac Incorporated to Release Fourth Quarter Results and CFO Video Update on February 4, 2026 and Host Webcast on February 5, 2026**
- Source: Yahoo Finance UK | 20260105T210807 | Neutral | Relevance: 100%
- Aflac Incorporated announced it will release its fourth-quarter 2025 financial results after the market closes on Wednesday, February 4, 2026. This release will be accompanied by a financial update video from CFO Max Brodén on the company's Investor Relations website. Additionally, Aflac will host a webcast conference call on Thursday, February 5, 2026, at 8:00 a.m. ET, where company leaders will discuss results and answer questions.

**4. Aflac Incorporated to Release Fourth Quarter Results and CFO Video Update on February 4, 2026 and Host Webcast on February 5, 2026**
- Source: Yahoo Finance | 20260105T210730 | Neutral | Relevance: 100%
- Aflac Incorporated (NYSE: AFL) announced it will release its fourth quarter 2025 financial results on February 4, 2026, followed by a webcast on February 5, 2026. The webcast will feature CEO Daniel P. Amos and CFO Max Brodén discussing quarterly results, joined by other executives to answer questions. Earnings materials and a CFO video update will be available on the company's Investor Relations website.

**5. JP Morgan Raises Price Target for Aflac (AFL) to $105.00 | AFL S**
- Source: GuruFocus | 20260105T132052 | Somewhat-Bullish | Relevance: 100%
- JP Morgan has maintained its 'Neutral' rating for Aflac (AFL) while increasing its price target from $101.00 to $105.00, representing a 3.96% rise. This adjustment comes amidst other recent analyst rating changes for Aflac, which provides supplemental health and life insurance in the US and Japan. The average target price from 13 analysts is $111.31, implying a slight upside from its current price.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | JP Morgan | $105 | $101 | +4% |
| 2025-12-30 | Raymond James | $119 | $110 | +8% |
| 2025-12-22 | TD Cowen | $102 | $100 | +2% |
| 2025-12-16 | Mizuho | $104 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | JP Morgan | main | Neutral |
| 2025-12-30 | Raymond James | main | Outperform |
| 2025-12-22 | TD Cowen | main | Hold |
| 2025-12-16 | Mizuho | init | Underperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.27M) |
| Sells | 10 ($2.69M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.3% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Japan Post Holdings : 10.0% (0.0%)
- Vanguard Group Inc: 9.6% (-0.8%)
- Blackrock Inc.: 7.4% (+0.1%)
- State Street Corpora: 4.6% (+0.1%)
- Wells Fargo & Compan: 2.1% (-24.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +5%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.93 indicates undervaluation relative to growth. Quality metrics strong (margin 24%). Balance sheet: strong liquidity (48.2x). Insider selling cluster ($2.7M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $59.9B |
| Beta | 0.66 |
| 52W Range | $96.95 - $115.84 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.93 |
| Forward P/E | 15.2 |
| Current P/E | 14.7 |
| YoY Growth | -3.3% |
| EPS Direction | RISING |

### Technicals

MRS_10 improving modestly (+0.7% over 5 days). Below STRENGTH zone by 2.2pp (needs >3.0% for momentum thesis). MRS_5 at 0.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 59. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.76% (CS: 46) | Neutral |
| RSI_14 | 58.7 | Neutral |
| MACD Histogram | 0.22 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.016x | Above |
| vs SMA200 | 1.047x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $111.97
- **Stop Loss:** $108.55 (3.1% risk)
- **Target:** $115.39 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 385
- **Position Value:** $43,108.45
- **Portfolio %:** 43.11%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-02-04 (Est: $1.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $2.49 | +40.2% |
| 2025Q2 | $1.71 | $1.78 | +4.3% |
| 2025Q1 | $1.67 | $1.66 | -0.8% |
| 2024Q4 | $1.62 | $1.56 | -3.5% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*